$Humanigen, Inc.(HGEN)$ $HGENUK’s MHRA accepts Humanigen’s submission of Lenzilumab for Marketing Authorization in COVID-19 for expedited rolling review Despite surging cases , UK still plans a full reopening on July 17th. We can only hope that the MHRA have earmarked accelerated authorization for Lenzilumab to treat patients that become hospitalized as a result of this disastrous political decision.